Eastwood Bio-Medical Canada Inc. (TSXV:EBM)

Market Cap	24.80M
Revenue (ttm)	702.08K
Net Income (ttm)	-455.87K
Shares Out	68.89M
EPS (ttm)	-0.01
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,570
Average Volume	1,097
Open	0.4100
Previous Close	0.3600
Day's Range	0.3600 - 0.4100
52-Week Range	0.2800 - 1.1500
Beta	-0.04
RSI	34.22
Earnings Date	Feb 27, 2025

About TSXV:EBM

Eastwood Bio-Medical Canada Inc. markets and distributes natural health products under the Eleotin brand in Canada, the United States, and Asia. The company distributes Eleotin that provide natural remedies for metabolic disorders, such as blood glucose disorders, hypertension, and obesity. Its licensed products include Eleotin A 700 for the treatment for spleen deficiency, lack of appetite, and fatigue; Eleotin AL88 for laxative; Eleotin Cal20 for bone and teeth maintenance; Eleotin V3D for development and maintenance of bones, teeth, and good...

• Industry: Food Distribution
• Sector: Consumer Staples
• Founded: 2010
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: EBM

Financial Performance

In 2024, TSXV:EBM's revenue was 702,076, a decrease of -19.11% compared to the previous year's 867,936. Losses were -455,870, -16.60% less than in 2023.